MarketReportsOnline.com adds Renal Cell Carcinoma - Global Drugs Market Forecast and Pipeline Analysis to 2021 research report of 148 pages on the renal cell carcinoma industry to the pharmaceuticals intelligence collection of its research store.

Pune, Maharashtra -- (SBWire) -- 02/02/2017 --Renal cell carcinoma is the most common type of kidney cancer in adults. It accounts for approximately 3% of adult malignancies and 90-95% of neoplasms arising from the kidney. The global renal cell carcinoma drugs market is anticipated to cross US$ 4.3 Billion mark by 2021. There are many factors, like smoking, hypertension, unhealthy eating habits and family history, which increase the risk of occurrence of renal cell carcinoma. The major driving factors for the renal cell carcinoma drugs market are increasing risk of lifestyle induced diseases, growing prevalence of renal cell carcinoma, increasing geriatric population base and quick diagnosis with modern imaging techniques.

Purchase a copy of this research report at http://www.marketreportsonline.com/contacts/purchase.php?name=481229.

The major drugs used for the treatment of renal cell carcinoma include Sutent, Nexavar, Votrient, Avastin and Inyta amongst others. Sutent accounts for largest share of the global renal cell carcinoma drugs market in 2015, while, Votrient is projected to witness the strongest growth during the forecasting period. The most recent drugs approved for the treatment of renal cell carcinoma is Bristol-Myers Squibb's Opdivo. Moreover, there are many pipeline drugs in various phases of clinical trials, which will fuel the growth of renal cell carcinoma drugs market.

"Renal Cell Carcinoma - Global Drugs Market Forecast and Pipeline Analysis to 2021" provides a comprehensive analysis of the fast-evolving high growth renal cell carcinoma therapeutics market.

This 148 Page report with 58 Figures and 4 Tables has been analyzed from 7 viewpoints:
1. Renal Cell Carcinoma (RCC) - Disease Overview
2. Renal Cell Carcinoma (RCC) - Epidemiology
3. Global Renal Cell Carcinoma - Diagnosed Incident Cases to 2023 (8 Countries Covered)
4. Global Renal Cell Carcinoma - Five-Year Diagnosed Prevalent Cases to 2023 (8 Countries Covered)
5. Global Renal Cell Carcinoma - Major Branded Drugs Product Profiles and Sales Analysis to 2021 (11 Brands Covered)
6. Global Renal Cell Carcinoma Drugs - Pipeline Analysis (18 Drugs Covered)
7. Global Renal Cell Carcinoma Drugs - Market Drivers and Restraints

Global Renal Cell Carcinoma - Diagnosed Incident Cases and Five-Year Diagnosed Prevalent Cases to 2023 (8 Countries Covered): United states, Italy, Germany, France, United Kingdom, Spain, Japan, China

Complete report available at http://www.marketreportsonline.com/481229.html.

Global Renal Cell Carcinoma - Major Branded Drugs Product Profiles and Sales Analysis to 2021 (11 Brands Covered)
- Sutent (Sunitinib)
- Nexavar (Sorafenib)
- Votrient (Pazopanib)
- Avastin (Bevacizumab)
- Afinitor (Everolimus)
- Inlyta (Axitinib)
- Torisel (Temsirolimus)
- Proleukin (Aldesleukin)
- Opdivo (Nivolumab) - Product Profile
- Tarceva (Erlotinib) - Product Profile
- Interferon-alfa - Product Profile

Global Renal Cell Carcinoma Drugs - Pipeline Analysis (17 Companies Drugs Covered)
- Merck & Co., Inc.
- Exelixis Inc
- Argus Therapeutics, Inc.
- Bristol-Myers Squibb
- Genentech/Roche
- Immatics Biotechnologies
- AVEO Oncology
- Eisai
- Acceleron
- Rexahn Pharmaceuticals
- Bionomics
- Cerulean Pharma Inc
- Celldex Therapeutics
- TVAX Biomedical
- TRACON Pharmaceuticals
- Eli Lilly
- AstraZeneca

Key Topics Covered in (http://www.marketreportsonline.com/481229-toc.html) Global Renal Cell Carcinoma Market:
1. Executive Summary
2. Renal Cell Carcinoma (RCC) - Disease Overview
3. Renal Cell Carcinoma (RCC) – Epidemiology
4. Global Renal Cell Carcinoma - Epidemiological Forecast (2012 - 2023)
5. Global Renal Cell Carcinoma (RCC) - Diagnosed Incident Cases and Five-Year Diagnosed Prevalent Cases (2012 - 2023)
6. Global Renal Cell Carcinoma - Drugs Market Analysis (2012 - 2021)
7. Global Renal Cell Carcinoma - Major Branded Drugs Product Profiles and Sales
8. Global Renal Cell Carcinoma Drugs Market - Company Wise Pipeline Analysis
9. Global Renal Cell Carcinoma Drugs - Market Drivers
10. Global Renal Cell Carcinoma Drugs - Market Restraints

Explore More Related Reports on Pharmaceuticals Market at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.

About MarketReportsOnline
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Contact Us:
Ritesh Tiwari
2nd Floor, Metropole,
Next to Inox Theatre,
Bund Garden Road,
Pune - 411001.
Maharashtra, India.
Tel: 888-391-5441
E-mail: sales@marketreportsonline.com